• Explore /
  • Poster
  • / Nab paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after failure of folfirinox: Results of an AGEO multicenter prospective cohort.

Nab paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after failure of folfirinox: Results of an AGEO multicenter prospective cohort.

Abstract Poster

Authors

null

Alix Portal

Hopital Européen Georges Pompidou, Paris, France

Alix Portal , Simon Pernot , Claire Arbaud , David Tougeron , Anne Thirot-Bidault , Christelle De La Fouchardiere , Pascal Hammel , Thierry Lecomte , Johann Dreanic , Romain Coriat , Jean Baptiste Bachet , Olivier Dubreuil , Lysiane Marthey , Laetitia Dahan , Jean-Louis Legoux , Christophe Locher , Céline Lepère , Philippe Rougier , Franck Bonnetain , Julien Taieb

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 4123)

DOI

10.1200/jco.2015.33.15_suppl.4123

Abstract #

4123

Poster Bd #

235

Abstract Disclosures

Similar Posters

Poster

2017 Gastrointestinal Cancers Symposium

Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.

Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.

First Author: Masato Ozaka

First Author: Renata D'Alpino Peixoto

First Author: Li-Tzong Chen

First Author: Timil Patel